{"uri":"hbv-dna-real-time-quantification-according-to-arns-kw4cxgw","version_id":"0","protocol_name":"HBV DNA Real Time Quantification according to ARNS 12187 project","protocol_name_html":"HBV DNA Real Time Quantification according to ARNS 12187 project","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1519250854","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0190592","fork_id":"","public_fork_note":null,"number_of_steps":"0","has_versions":"0","first_published_date":"1511342516","publish_date":"2018-01-10 18:07:09","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p><strong><u>HBV DNA Real Time Quantification according to ARNS 12187 project<\/u><\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Using the Arrow extractor (NorDiag, Biotrin International, Ireland), DNA was extracted from 240 \u03bcl of plasma, pre-treated with10 \u03bcl of proteinase K, using the Arrow Viral NA extraction kit, according to the manufacturer\u2019s instructions during 45 min. Template DNA was eluted into 60 \u03bcl of kit elution buffer. Besides clinical samples, quantification standard (Acrometrix HBV Panel, Acrometrix, Menica, CA, USA) was also extracted for each run with the same protocol and1:10 diluted (from 50,000,000IU\/mL to50IU\/mL). For amplification, we used a primers\/probe set designed under the auspices of \u201cAgence Nationale de Recherches sur le SIDA et les h\u00e9patites virales\u201d (ANRS 12187 project) and targeting a conserved region in the HBVS gene (nucleotide (nt) positions, 379\u2013426). All runs were performed in a 50-\u03bcl volume containing DNA extract (10 \u03bcl), Master Mix (Platinum UGD, USA) (25 \u03bcl), pure water (HyClone Pure Water, Thermo Fisher Scientific, Waltham, MAUSA)(12.5 \u03bcl), forward primHBV1 (5\u2019-GTGTCTGCGGCGTT TTATCA-3\u2019) and reverse primHBV2 (5\u2019-AGGCATAGCAGCAGGAT GAA-3\u2019) primers at 10 \u03bcM (1\u03bcl each) and probe (5\u2019FAM-TGCGGCGTTTTATCAT-MGB3\u2019) at 5\u03bcM (0.5 \u03bcl). Each reaction consisted of: 2min at50\u00b0C and 10min at95\u00b0C; followed by 50 cycles of 15sec at 95\u00b0C and 1 min at 60\u00b0C each. The lower limit of quantification (LLOQ) of our technique was 100IU\/mL and the lower limit of detection (LLOD) was 50IU\/mL.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"8892","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1511340921","protocol_affiliation":"Unit\u00e9 Mixte de Recherche VIH et Maladies Infectieuses Associ\u00e9es (UMR-VIH-MIA), Libreville, Gabon,Laboratoire de R\u00e9trovirologie, Centre International de Recherches M\u00e9dicales de Franceville (CIRMF), Franceville, Gabon,Centre de Traitement Ambulatoire (CTA), Franceville, Gabon,Laboratoire de R\u00e9trovirologie, Centre International de Recherches M\u00e9dicales de Franceville (CIRMF),Service de Virologie, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroun,Laboratoire de Virologie, AP-HP, H\u00f4pital Saint Louis; INSERM U941,Universit\u00e9 Paris Diderot; Laboratoire associ\u00e9 au Centre national de R\u00e9f\u00e9rence du VIH, Paris, France","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.kw4cxgw","doi_status":"2","changed_fork_steps":null,"profile_url":"y2w25413y2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/012.png","full_name":"Berthold BIVIGOU-MBOUMBA","created_by":"Berthold BIVIGOU-MBOUMBA","private_link":"0BEA8EC140ADADDFF50579B761A40A61","original_img":"1","username":"berthold-bivigoumboumba","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0190592","manuscript_citation":"Bivigou-Mboumba B,  Amougou-Atsama M,  Zoa-Assoumou S,  Kamdem HM,  Nzengui-Nzengui GF,  Ndojyi-Mbiguino A,  Njouom R,  Fran\u00e7ois-Souqui\u00e8re S (2018) Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS ONE  13(1): e0190592. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0190592\">10.1371\/journal.pone.0190592<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":275993,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Berthold Bivigou-Mboumba,Sandrine Fran\u00e7ois-Souqui\u00e8re,Luc Deleplancque,Jeanne Sica,Augustin Mouinga-Ond\u00e9m\u00e9,Marie Amougou-Atsama,Marie Laure Chaix,Richard Njouom,Fran\u00e7ois Rouet","authors_list":[{"name":"Berthold Bivigou-Mboumba","affiliation":"Unit\u00e9 Mixte de Recherche VIH et Maladies Infectieuses Associ\u00e9es (UMR-VIH-MIA), Libreville, Gabon","username":null,"profile_image":null},{"name":"Sandrine Fran\u00e7ois-Souqui\u00e8re","affiliation":"Unit\u00e9 Mixte de Recherche VIH et Maladies Infectieuses Associ\u00e9es (UMR-VIH-MIA), Libreville, Gabon","username":null,"profile_image":null},{"name":"Luc Deleplancque","affiliation":"Laboratoire de R\u00e9trovirologie, Centre International de Recherches M\u00e9dicales de Franceville (CIRMF), Franceville, Gabon","username":null,"profile_image":null},{"name":"Jeanne Sica","affiliation":"Centre de Traitement Ambulatoire (CTA), Franceville, Gabon","username":null,"profile_image":null},{"name":"Augustin Mouinga-Ond\u00e9m\u00e9","affiliation":"Laboratoire de R\u00e9trovirologie, Centre International de Recherches M\u00e9dicales de Franceville (CIRMF)","username":null,"profile_image":null},{"name":"Marie Amougou-Atsama","affiliation":"Service de Virologie, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroun","username":null,"profile_image":null},{"name":"Marie Laure Chaix","affiliation":"Laboratoire de Virologie, AP-HP, H\u00f4pital Saint Louis; INSERM U941,Universit\u00e9 Paris Diderot; Laboratoire associ\u00e9 au Centre national de R\u00e9f\u00e9rence du VIH, Paris, France","username":null,"profile_image":null},{"name":"Richard Njouom","affiliation":"Service de Virologie, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroun","username":null,"profile_image":null},{"name":"Fran\u00e7ois Rouet","affiliation":"Laboratoire de R\u00e9trovirologie, Centre International de Recherches M\u00e9dicales de Franceville (CIRMF)","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/012.png","username":"berthold-bivigoumboumba","full_name":"Berthold BIVIGOU-MBOUMBA","created_by":"Berthold BIVIGOU-MBOUMBA"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":null,"status_info":null,"steps":[]}